Therapy for inflammatory breast cancer: Impact of doxorubicin-based therapy
Authors:
- 1 July 1995
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 2 (4) , 288-294
Abstract
Background: Inflammatory breast cancer (IBC) carries an ominous prognosis. Before 1988, women with IBC at our institution were treated with neoadjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with or without vincristine and prednisone (CMF/VP). After 1988, women with IBC were treated with cyclophosphamide, doxorubicin, and 5-fluorouracil (FAC). This study compares these two regimens with regard to response and survival. Methods: The records of all women presenting between January 1973 and December 1991 with a stage IIIB (T4d, any N, MO) breast cancer with proven dermal lymphatic invasion by tumor cells were reviewed retrospectively. Results: The study comprised 38 women; 28 received CMF (22 CMF, 6 CMF/VP), and 10 received FAC. The overall response rate to induction chemotherapy in the CMF/VP group was 57% (40% PR, 17% CR), and 100% (60% PR, 40% CR) in the FAC group. The median overall survival for women receiving CMF/VP was 18 months compared with 30 months for women receiving FAC (p=0.02). The median disease-free survivals for the CMF/VP and FAC groups were 6 and 24 months, respectively (pConclusion: This study suggests that a doxorubicin-containing chemotherapy regimen improves overall and disease-free median survivals when compared with the previously used CMF combination in the treatment of IBC. A favorable response to induction chemotherapy also appeared to be associated with an improved survival.Keywords
This publication has 24 references indexed in Scilit:
- Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysisCancer, 1987
- Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy.Journal of Clinical Oncology, 1986
- Inflammatory carcinoma of the breast. Clinical review and summary of the vanderbilt experience with multi-modality therapyThe American Journal of Medicine, 1985
- A Multifactorial Analysis of Steroid Hormone Receptors in Stages I and II Breast CancerAnnals of Surgery, 1985
- Inflammatory cancer of the breast: Analysis of 114 casesJournal of Surgical Oncology, 1981
- Inflammatory carcinoma of the breastClinical Radiology, 1964
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Inflammatory carcinoma of the breast: A report of 20 cases and a review of the literatureBritish Journal of Surgery, 1950
- A STUDY OF CARCINOMA MASTITOIDESAnnals of Surgery, 1911
- PEAU D'ORANGE IN ACUTE MAMMARY CARCINOMA: ITS CAUSE AND DIAGNOSTIC VALUE.The Lancet, 1909